Nuclear Medicine: Page 62

Ga-68 PSMA-11 PET/MRI improves prostate cancer detection

By Wayne Forrest

VIENNA - PET/MRI with the radiopharmaceutical gallium-68 (Ga-68) prostate-specific membrane antigen-11 (PSMA-11) could become a valuable tool in image-guided biopsy and for detecting significant prostate cancer, researchers reported on Wednesday at ECR 2019.

February 28, 2019

Be aware of artifacts to improve hybrid imaging outcomes

By Frances Rylands-Monk

Awareness of possible artifacts and pitfalls in hybrid imaging is the first step in dealing with them, ECR 2019 delegates learned in a session during the opening day of the congress. The presenters also discussed new types of problems and challenges that may occur with the clinical application of novel specific tracers.

February 26, 2019

Can mobile phones affect gamma camera performance?

By Wayne Forrest

Mobile phones can sometimes be a nuisance in daily life, but in a nuclear medicine suite, electromagnetic interference emitted by phones could even adversely affect the performance of gamma cameras, according to a study published in the March issue of the Journal of Medical Imaging and Radiation Sciences.

February 26, 2019

Radiotracer contaminates crematorium after patient dies

By Brian Casey

Radiation from a radiopharmaceutical used to treat a patient who later died contaminated equipment at an Arizona crematorium in 2017, according to a research letter published in the Journal of the American Medical Association.

February 26, 2019

ImaginAb taps new CEO

By AuntMinnie.com staff writers

Imaging agent developer ImaginAb has appointed Ian Wilson as its new CEO, effective immediately.

February 25, 2019

AuntMinnie.com Molecular Imaging Insider

By Wayne Forrest

February 24, 2019

DOE to fund U.S. Mo-99 production

By AuntMinnie.com staff writers

The U.S. Department of Energy's (DOE) National Nuclear Security Administration has set the stage to begin negotiations with four companies to produce molybdenum-99 (Mo-99) in the U.S.

February 20, 2019

Bicycle Therapeutics makes executive changes

By AuntMinnie.com staff writers

Biotechnology firm Bicycle Therapeutics has appointed Peter Leone as chief business officer and promoted Lee Kalowski from chief financial officer to president of the company's U.S. subsidiary.

February 19, 2019

Lantheus posts sales gains, earnings dip in Q4

By AuntMinnie.com staff writers

Driven by strong worldwide sales of its Definity ultrasound contrast agent, Lantheus Holdings reported a 6.2% sales gain in its fourth quarter. Net income declined, however, due to adjustments in tax reporting completed in 2017.

February 19, 2019

New PET/CT tracer effectively targets blood clots

By Wayne Forrest

Researchers from South Korea and Germany are reporting excellent image quality and a high detection rate with PET/CT for acute venous thromboembolism thanks to a new radiotracer currently being developed, according to a paper published in the February issue of the Journal of Nuclear Medicine.

February 17, 2019

Bicycle Therapeutics touts peptide study

By AuntMinnie.com staff writers

Bicycle Therapeutics is riding high on the findings of a study published in the February 15 issue of Cancer Research. Results suggest the company's proprietary bicyclic peptide platform is a potentially valuable therapeutic tool for molecular imaging and diagnostics.

February 14, 2019

FFNP-PET could aid breast cancer treatment evaluation

By AuntMinnie.com staff writers

PET imaging with fluoro furanyl norprogesterone (FFNP) could provide a new option for measuring changes in progesterone receptor levels due to estrogen treatment for breast cancer, according to a study published in the February issue of the Journal of Nuclear Medicine.

February 11, 2019

Previous Page

Page 62 of 440

Next Page